Incorporation of Pharmacokinetic and Pharmacodynamic Data into Risk Assessments

REFERENCES

• Abraham, M., Kamlet, M. J., Taft, R. W., Doherty, R. M., and Weathersby, P. K. 1985. Solubility properties in polymers and biological media. 2. The correlation and prediction of the solubilities of nonelectrolytes in biological tissues and fluids. J. Med. Chem. 28:865–870.
   PubMed Web of Science ®Google Scholar
• Abraham, M. H., and Weathersby, P. K. 1994. Hydrogen bonding. 30. Solubility of gases and vapors in biological liquids and tissues. J. Pharm. Sci. 83:1450–1456.
   PubMed Web of Science ®Google Scholar
• Arias, I. M., Popper, H., Schachter, D., and Shafritz, D. A. 1982. The Liver: Biology and Pathobiology, New York: Raven Press.
   Google Scholar
• Arms, A. D., and Travis, C. C. 1988. Reference physiological parameters in pharmacokinetic modeling, US EPA/600/6-88/004, Final Report, NTIS, PB88–196019.
   Google Scholar
• Billings, R. E., McMahon, R. E., Ashmore, J., and Wagle, S. R. 1977. The metabolism of drugs in isolated rat hepatocytes: A comparison with in vivo drug metabolism and drug metabolism in subcellular liver fractions. Drug Metab.Dispos. 5:518–526.
   PubMed Web of Science ®Google Scholar
• Clewell, H. J., and Andersen, M. E. 1994. Physiologically based pharmacokinetic modeling andbioactivationofxenobiotics. Toxicol. Ind. Health 10:1–24.
   PubMed Web of Science ®Google Scholar
• Clewell, H. J., III and Andersen, M. E. 1996. Use of Physiologically based pharmacokinetic modeling to investigate individual versus population risk. Toxicology 111:315–329.
   PubMed Web of Science ®Google Scholar
• Clewell, H. J., Gentry, P. R., Gearhart, J. M., Covington, T. R., Banton, M. I., and Andersen, M. E. 2001. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol. Sci. 63:160–172.
   PubMed Web of Science ®Google Scholar
• Clewell, H. J., Gentry, P. R., Covington, T. R., Sarangapani, R., and Teeguarden, J. G. 2004. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. (in press).
   Google Scholar
• Clewell, H. J., Teeguarden, J., McDonald, T., Sarangapani, R., Lawrence, G., Covington, T., Gentry, P. R., and Shipp, A. M. 2002. Review and evaluation of the potential impact of age and gender-specific pharmacokinetic differences on tissue dosimetry. Crit. Rev. Toxicol. 32:329–389.
   PubMed Web of Science ®Google Scholar
• Clewell, R. A., and Gearhart, J. M. 2002. Pharmacokinetics of toxic chemicals in breast milk: Using PBPK models to predict infant exposure. Environ. Health Perspect. 110:A333–337.
   PubMed Web of Science ®Google Scholar
• Connell, D. W., Braddock, R. D., and Mani, S. V. 1993. Prediction of partition coefficients of liphoilic compounds in the air-mammal tissue system. Sci Total Environ. Suppl. 2:1383–1396.
   Google Scholar
• DeJongh, J., Verhaar, H. J., and Hermens, J. L. 1997. A quantitative property-property relationship QPPR approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans. Arch. Toxicol. 72:17–25.
   PubMed Web of Science ®Google Scholar
• Ekins, S., Murray, G. I., Burke, M. D., Williams, J. A., Marchant, N. C., and Hawksworth, G. M. 1995. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. DrugMetab. Dispos. 23:1274–1279.
   PubMed Web of Science ®Google Scholar
• Gearhart, J. M., Mahle, D. A., Greene, R. J., Seckel, C. S., Flemming, C. D., Fisher, J. W., Clewell, H. J. 1993. Variability of physiologically-based pharmacokinetic (PB-PK) model parameters and their effects on PB-PK model predictions in a risk assessment for perchloroethylene. Toxicol. Lett. 68:131–144.
   PubMed Web of Science ®Google Scholar
• Gentry, P. R., Covington, T. R., and Clewell, H. J. 2003. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Reg. Toxicol. Pharmacol. 38(1):1–16.
   PubMed Web of Science ®Google Scholar
• Gentry, P. R., Hack, C. E., Haber, L., Maier, A., and Clewell, H. J. 2002. An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: Examples with warfarin and parathion. Toxicol. Sci. 70:120–139.
   PubMed Web of Science ®Google Scholar
• Gearhart, J. M., Jepson, G. W., Clewell, H. J., Andersen, M. E., and Connoly, R. B. 1994. “Physiologically based pharmacokinetic model forthe inhibition of acetylcholinesterase by organophosphate esters.” Environ. Health Perspect. 102(Suppl 11):51-60.
   PubMedGoogle Scholar
• Haber, L. T., Maier, A., Gentry, P. R., Clewell, H. J., and Dourson, M. L. 2002. Genetic polymorphisms in assessing interindividual variability in delivered dose. Reg.Tox. Pharm. 35:177–197.
   PubMed Web of Science ®Google Scholar
• Hansch, C., and Leo, A. 1995. QSAR in metabolism, In Exploring QSAR: Fundamentals and applications in chemistry and biology, eds. C. Hansch, and A. Leo, 299-343. ACS professional reference book of American Chemical Society, Washington DC.
   Google Scholar
• Houston, J. B. 1994. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 47:1469–1479.
   PubMed Web of Science ®Google Scholar
• International Commission on Radiological Protection (ICRP). 1975. In Report of the task Group on Reference Man, eds. W. S. Snyder, M. J. Cook, L. R.
   Google Scholar
• Karhausen, E. S. Nasset, G. P. Howells, and I. H. Tipton. Pergamon Press: Oxford, UK.
   Google Scholar
• International Programme on Chemical Safety (IPCS). 1994 Environmental Health CriteriaNo.170: Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health-based Exposure Limits. World Health Organization, Geneva.
   Google Scholar
• International Programme on Chemical Safety (IPCS) 2001. Guidance Document for the Use of Data in Development of Chemical-Specific Adjustment Factors (CSAFs) for Interspecies differences and Human Variability in Dose/Concentration-Response Assessment. World Health Organization, Geneva. http://www.ipcsharmonize.org
   Google Scholar
• Kalizan, R., and Markuszewski, M. 1996. Brain/blood distribution described by a combination of partition coefficients and molecular mass. Int. J. Pharmacol. 145:9–16.
   Google Scholar
• Kaneko, T., Wang, P. Y., and Sato, A. 1994. Partition coefficients of some acetate esters and alcohol in water, blood, olive oil, and rat tissues. Occup. Environ. Med. 51:68–72.
   PubMed Web of Science ®Google Scholar
• Kedderis, G. L. 1997a. Toxicokinetics: Biotransformation of Toxicants. In Comprehensive Toxicology eds. I. G. Sipes, C. A. McQueen, and A. J. Gandolfi, Volume 1 General Principles. ed. J. Bond, 135–148. Oxford: Elsevier Science Ltd.
   Google Scholar
• Kedderis, G. L. 1997b. Extrapolation of In Vitro Enzyme Induction Data to Humans In Vivo, Chem.-Biol. Interact. 107:109–121.
   Google Scholar
• Kedderis, G. L., Carfagna, M. A., Held, S. D., Batra, R., Murphy, J. E., and Gargas, M. L. 1993. Kinetic Analysis of Furan Biotransformation by F-344 Rats In Vivo and In Vitro. Toxicol. Appl. Pharmacol. 123:274–282.
   PubMed Web of Science ®Google Scholar
• Kedderis, G. L., and Held, S. D. 1996. Prediction of furan pharmacokinetics from hepatocyte studies: Comparison of bioactivation and hepatic dosimetry in rats, mice, and humans. Toxicol. Appl. Pharmacol. 140:124–130.
   PubMed Web of Science ®Google Scholar
• Krishnan, K., and Andersen, M. E. 2001. Physiologically-based Phamacokinetic Modeling in Toxicology. In Principles and Methods in Toxicology ed. W. Hayes, 193–141. New York: Taylor & Francis.
   Google Scholar
• Laass, W. 1987. Estimation of blood/air partition coefficients of organic solvents, in QSAR in drug design and toxicology, eds. D. Hadzi, and B. Jerman-Balzic, (pp. 131-134). Elsevier Science Publishers: Amsterdam.
   Google Scholar
• Lipscomb, J. C., Garrett, C. M., and Snawder, J. E. 1997. Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans. Toxicol. Appl. Pharmacol. 142:311–318.
   PubMed Web of Science ®Google Scholar
• Lipscomb, J. C., Teuschler, L. K., Swartout, J., Popken, D., Cox, T., and Kedderis, G. L. 2003a. The impact of cytochrome P450 2E1-dependent metabolic variance on a risk relevant pharmacokinetic outcome in humans. Risk Analysis 23:1221–1238.
   PubMed Web of Science ®Google Scholar
• Lipscomb, J. C., Teuschler, L. K., Swartout, J. C., Striley, C. A. F., and Snawder, J. E. 2003b. Variance of microsomal protein and cytochrome P450 2E1 and 3A forms in adult human liver. Toxicol. Mech. Methods. 13:45–51.
   PubMed Web of Science ®Google Scholar
• Lipscomb, J. C., and Kedderis, G. L. 2002. Incorporating human interindividual biotransformation variance in health risk assessment. Sci. Total Environ. 288:13–21.
   PubMed Web of Science ®Google Scholar
• Lombardo. F., Blake, J. F., and Curatolo, W. J. 1996. Computation of brain-blood partitioning of organic solutes via free energy calculations. J. Med. Chem. 39:4750–4755.
   PubMed Web of Science ®Google Scholar
• Meek, M. E. 2001. Categorical Default Uncertainty Factors—Interspecies variation and adequacy of database. Human Ecol. Risk Assess. 7:157–163.
   Web of Science ®Google Scholar
• Meek, M. E., Ohanian, E., Renwick, A., Naumann, B., Lake, B., Vu, V., and Dourson, M. 1999. Guidelines for application of data-derived uncertainty factors in risk assessment. Report of a Meeting by Toxicology Excellence for Risk Assessment for U.S. EPA/Health Canada, Washington, March 25th-26th.
   Google Scholar
• Meek, M. E., Ohanian, E., Renwick, A., Naumann, B., Lake, B., Vu, V., and Dourson, M. 2001. Guidelines for application of chemical-specific adjustment factors in dose/concentration assessment. Comments Toxicol. 7:575–590.
   Google Scholar
• Naumann, B. D., Silverman, K. C., Dixit, R., Faria, E. C., and Sargent, E. V. 2001. Case Studies of categorical data-derived adjustment factors. Human Ecol. Risk Asses. 7:61–106.
   Web of Science ®Google Scholar
• Northrop, D. B. 1983. Fitting enzyme-kinetic data to V/K Analyt. Biochem. 132:457–461.
   Web of Science ®Google Scholar
• Parham, F. M., Kohn, M. C., Mathews, H. B., DeRosa, C., and Portier, C. J. 1997. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated byphenyls. Toxicol. Appl. Pharmacol. 144:340–347.
   PubMed Web of Science ®Google Scholar
• Perbellini, L., Brugnone, F., Caretta, D., and Maranelli, G. 1985. Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br. J. Ind. Med. 42:162–167.
   PubMedGoogle Scholar
• Pelekis, M. L., Poulin, P., and Krishnan, K. 1995. An approach for incorporating tissue composition data into physiologically based pharmacokinetic models. Toxicol. Ind. Health 11:511–522.
   PubMed Web of Science ®Google Scholar
• Poulin, P., and Krishnan, K. 1996. A mechanistic algorithm for predicting blood: Airpartition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin. Toxicol. Appl. Pharmacol. 136:131–137.
   PubMed Web of Science ®Google Scholar
• Renwick, A. G. 1993. Data-derived safety (uncertainty) factors for the evaluation of food additives and environmental contaminants. Food Addit. Contam. 10:275–305.
   PubMed Web of Science ®Google Scholar
• Renwick, A. G., and Lazarus, N. R. 1998. Human variability and noncancer risk assessment—An analysis of the default uncertainty factor. Regul. Toxicol. Pharmacol. 27(1 Pt 2):3-20.
   PubMed Web of Science ®Google Scholar
• Sarangapani, R., Gentry, P. R., Covington, T. R., Teeguarden, J. G., and Clewell, H. J. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol. 10:987–1016.
   Google Scholar
• Seydel, J. K., and Schaper, K. J. 1982. Quantitative structure-pharmacokinetic relationships and drug design. Pharmacol. Ther. 15:131–182.
   Web of Science ®Google Scholar
• Sirica, A. E., and Pitot, H. C. 1980. Drug metabolism and effects of carcinogens in cultured hepatic cells, Pharmacol. Rev. 31:205–228.
   Web of Science ®Google Scholar
• Snawder, J. E., and Lipscomb, J. C. 2000. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: Correlation of individual forms with xenobiotic metabolism and implications for risk assessment. Regul. Toxicol. Pharmacol. 32:200–209.
   PubMed Web of Science ®Google Scholar
• US Environmental Protection Agency (US EPA) Office of Pollution Prevention Toxics and Syracuse Research Corporation. 2003. Estimation Program Interface (EPI) Suites. Available online at: http://www.epa.gov/ opptintr/exposure/docs/episuite.htm.
   Google Scholar
• Worboys, P. D., Brennan, B., Bradbury, A., and Houston, J. B. 1996. Metabolite kinetics of ondansetron in rat. Comparison of hepatic microsomes, isolated hepatocytes and liver slices, with in vivo disposition, Xenobiotica 26:897–907.
   Google Scholar